Related Experiment Video
Updated: May 17, 2025

07:22
A High-throughput Cre-Lox Activated Viral Membrane Fusion Assay to Identify Inhibitors of HIV-1 Viral Membrane Fusion
Published on: August 14, 2018
6.3K
ANALYSIS OF FACTORS THAT REGULATE HIV-1 FUSION IN REVERSE
Biorxiv : the Preprint Server for Biology
|March 31, 2025
Summary
Researchers explored a novel "fusion in reverse" method to infect HIV-1. This approach targets latent HIV-1 infections by utilizing cellular envelope proteins to mediate viral entry, offering new insights into HIV-1 envelope protein functions.
Area of Science:
- Virology
- Cell Biology
- Immunology
Background:
- HIV-1 envelope (Env) proteins mediate viral entry by fusing with host cells expressing CD4 receptors and CXCR4 co-receptors.
- Cellular Env proteins can also mediate fusion with enveloped viruses or cells expressing CD4 and CXCR4.
Purpose of the Study:
- To investigate the mechanism of "fusion in reverse," where cellular Env proteins mediate fusion with lentiviral vectors.
- To identify factors influencing this novel infection pathway and its potential for targeting latent HIV-1.
Main Methods:
- Utilized lentiviral vectors pseudotyped with CD4 and CXCR4 variants.
- Tested infection of Env-expressing cells using the "fusion in reverse" mechanism.
- Assessed the impact of cell surface Env levels, fusion inhibitors, and lipid membrane composition on infectivity.
Main Results:
- Infection via "fusion in reverse" depends on cell surface Env levels and is inhibited by a specific fusion inhibitor.
- Optimal infection required lentiviral vectors with a GPI-anchored CD4 variant and a truncated CXCR4.
- Latently HIV-1-infected cells were specifically infected, with higher efficiency upon activation.
- Viruses produced in sphingolipid-deficient cells showed increased infectivity, while those with a lipid scramblase were non-infectious.
Conclusions:
- "Fusion in reverse" is a viable mechanism for infecting Env-expressing cells, including latently HIV-1-infected cells.
- Cellular Env protein activity is modulated by the lipid composition of the viral and cellular membranes.
- This study provides new insights into HIV-1 envelope protein function and potential therapeutic strategies.

